Fuan Pharmaceutical Group Co - Asset Resilience Ratio

Latest as of September 2025: 1.34%

Fuan Pharmaceutical Group Co (300194) has an Asset Resilience Ratio of 1.34% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Fuan Pharmaceutical Group Co for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥80.01 Million
≈ $11.71 Million USD Cash + Short-term Investments

Total Assets

CN¥5.97 Billion
≈ $873.22 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Fuan Pharmaceutical Group Co's Asset Resilience Ratio has changed over time. See shareholders equity of Fuan Pharmaceutical Group Co for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Fuan Pharmaceutical Group Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Fuan Pharmaceutical Group Co market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥80.01 Million 1.34%
Total Liquid Assets CN¥80.01 Million 1.34%

Asset Resilience Insights

  • Limited Liquidity: Fuan Pharmaceutical Group Co maintains only 1.34% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Fuan Pharmaceutical Group Co Industry Peers by Asset Resilience Ratio

Compare Fuan Pharmaceutical Group Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Fuan Pharmaceutical Group Co (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Fuan Pharmaceutical Group Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.50% CN¥30.00 Million
≈ $4.39 Million
CN¥5.98 Billion
≈ $874.85 Million
+0.42pp
2023-12-31 0.08% CN¥5.05 Million
≈ $739.50K
CN¥5.98 Billion
≈ $874.47 Million
-0.17pp
2022-12-31 0.26% CN¥15.21 Million
≈ $2.23 Million
CN¥5.88 Billion
≈ $860.13 Million
-0.11pp
2021-12-31 0.37% CN¥20.86 Million
≈ $3.05 Million
CN¥5.71 Billion
≈ $835.03 Million
-0.90pp
2020-12-31 1.27% CN¥75.67 Million
≈ $11.07 Million
CN¥5.97 Billion
≈ $874.01 Million
-2.90pp
2019-12-31 4.17% CN¥197.31 Million
≈ $28.87 Million
CN¥4.74 Billion
≈ $693.02 Million
+2.86pp
2018-12-31 1.30% CN¥56.00 Million
≈ $8.19 Million
CN¥4.29 Billion
≈ $628.14 Million
-6.10pp
2017-12-31 7.40% CN¥347.00 Million
≈ $50.78 Million
CN¥4.69 Billion
≈ $686.12 Million
+3.28pp
2016-12-31 4.12% CN¥181.00 Million
≈ $26.49 Million
CN¥4.40 Billion
≈ $643.51 Million
-11.07pp
2015-12-31 15.18% CN¥376.42 Million
≈ $55.08 Million
CN¥2.48 Billion
≈ $362.77 Million
--
pp = percentage points

About Fuan Pharmaceutical Group Co

SHE:300194 China Drug Manufacturers - Specialty & Generic
Market Cap
$719.00 Million
CN¥4.91 Billion CNY
Market Cap Rank
#10706 Global
#3148 in China
Share Price
CN¥4.13
Change (1 day)
-0.24%
52-Week Range
CN¥3.81 - CN¥5.02
All Time High
CN¥10.53
About

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, generic drugs, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and… Read more